Epigallocatechin-3-gallate (EGCG) attenuates non-alcoholic fatty liver disease via modulating the interaction between gut microbiota and bile acids.

Naito, Yuji; Ushiroda, Chihiro; Mizushima, Katsura; Inoue, Ryo; Yasukawa, Zenta; Abe, Aya; Takagi, Tomohisa

Naito, Yuji; Ushiroda, Chihiro; Mizushima, Katsura; Inoue, Ryo; Yasukawa, Zenta; Abe, Aya; Takagi, Tomohisa.

Afiliação

Naito Y; Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto 602-8566, Japan.
Ushiroda C; Department of Endoscopy and Ultrasound Medicine, University Hospital, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto 602-8566, Japan.
Mizushima K; Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto 602-8566, Japan.
Inoue R; Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto 602-8566, Japan.
Yasukawa Z; Laboratory of Animal Science, Setsunan University, Nagaotoge-cho 45-1, Hirakata, Osaka 573-0101, Japan.
Abe A; Nutrition Division, Taiyo Kagaku Co., Ltd., 1-3 Takaramachi, Yokkaichi, Mie 510-0844, Japan.
Takagi T; Nutrition Division, Taiyo Kagaku Co., Ltd., 1-3 Takaramachi, Yokkaichi, Mie 510-0844, Japan.

J Clin Biochem Nutr ; 67(1): 2-9, 2020 Jul.

Article em En | MEDLINE | ID: mdl-32801462

Palavras-chave

dysbiosis; epigallocatechin-3-gallate; high-fat diet; nutrigenomics; taurine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Biochem Nutr Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google